Skip to main content
. 2017 Sep 27;8(50):87971–87979. doi: 10.18632/oncotarget.21313

Table 2. Univariate analyses of sensitivity to chemoradiotherapy in ESCC patients.

Factor N Responder Resistance Chi-square p value
Age
 ≤60 32 22 10 0.523 0.505
 >60 136 102 34
Sex
 Male 134 100 34 0.229 0.665
 Female 34 24 10
Smoking
 No 72 42 30 15.611 <0.001
 Yes 96 82 14
Tumour site
 Upper 1/3 60 54 10 5.979 0.05
 Middle 1/3 78 50 24
 Lower 1/3 30 20 10
T stage
 II/III 130 98 32 0.738 0.390
 IV 38 26 12
N stage
 0 44 34 10 0.370 0.690
 I 124 90 34
Clinic stage
 II 44 34 10 17.811 <0.001
 III 86 70 14
 IV 38 18 20
Adjuvant therapies
 RT 46 30 16 2.419 0.167
 CCRT 122 94 28
NLR
 ≤3.34 108 88 20 9.207 0.003
 >3.34 60 36 24
PLR
 ≤103.75 68 58 10 7.795 0.005
 >103.75 100 66 34
CNP
 0 score 64 64 10 15.283 <0.001
 1 score 48 38 10
 2 score 56 32 24
Hemoglobin level
 ≤43.98 80 50 30 10.105 <0.001
 >43.98 88 74 14